Konstantinos Xanthopoulos
Thessaloniki, ESYE12 54124, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Current genetic approaches for the treatment of prion diseases.
Journal: Neuroscience
Published: March 04, 2026
Titanium Dioxide Solar Photocatalytic Microbial Inactivation Assessment Utilizing Viability Tests and a Novel Triplex qPCR Assay for Nucleic Acid Degradation Determination.
Journal: Molecules (Basel, Switzerland)
Published: September 01, 2025
The deubiquitinase activity of CYLD is required for B cell differentiation.
Journal: Cell death & disease
Published: August 07, 2025
Serum and Liver Lipidome Following Empagliflozin Administration for Six Months in a Fast Food Diet Mouse Model.
Journal: International journal of molecular sciences
Published: July 07, 2025
Molecularly designed deep eutectic solvents based on choline for site-specific delivery of luteolin in the oral cavity.
Journal: International journal of pharmaceutics
Published: June 14, 2025
Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet.
Journal: Hormones (Athens, Greece)
Published: July 30, 2024
SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal Dementia.
Journal: Biomedicines
Published: April 29, 2024
RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: April 04, 2024
A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis.
Journal: Pathogens (Basel, Switzerland)
Published: April 03, 2024
Inactivation of the Tumor Suppressor CYLD Sensitizes Mice to Breast Cancer Development.
Journal: Anticancer research
Published: February 25, 2024
Last Updated: 09/26/2026